Author

Maria Jose Cabello Tapia

VEDOLIZUMAB IN REAL PRACTICE: EXPERIENCE IN A TERTIARY HOSPITAL
VEDOLIZUMAB IN REAL PRACTICE: EXPERIENCE IN A TERTIARY HOSPITAL

Maria Jose Cabello Tapia  et al.

INFLUENCE OF COVID-19 ON INFLAMMATORY BOWEL DISEASE PATIENTS AND BIOLOGICAL TREATMENT
INFLUENCE OF COVID-19 ON INFLAMMATORY BOWEL DISEASE PATIENTS AND BIOLOGICAL TREATMENT

Maria Jose Cabello Tapia  et al.

IMPACT OF USTEKINUMAB ON EXTRAINTESTINAL MANIFESTATIONS AND IMMUNOMEDIATED DISEASES IN A COHORT OF PATIENTS WITH ULCERATIVE COLITIS IN REAL LIFE: THE ULISES STUDY
IMPACT OF USTEKINUMAB ON EXTRAINTESTINAL MANIFESTATIONS AND IMMUNOMEDIATED DISEASES IN A COHORT OF PATIENTS WITH ULCERATIVE COLITIS IN REAL LIFE: THE ULISES STUDY

Maria Jose Cabello Tapia  et al.

REAL WORLD EVIDENCE OF USTEKINUMAB IN ULCERATIVE COLITIS: SHORT AND LONG-TERM EFFECTIVENESS AND SAFETY: THE ULISES STUDY
REAL WORLD EVIDENCE OF USTEKINUMAB IN ULCERATIVE COLITIS: SHORT AND LONG-TERM EFFECTIVENESS AND SAFETY: THE ULISES STUDY

Maria Jose Cabello Tapia  et al.

LONG-TERM EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
LONG-TERM EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Maria Jose Cabello Tapia  et al.

Item 1 - 5 / 5
1